13F-HR filed by Casdin Capital, LLC
Casdin Capital, LLC filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-12, with 26 holding rows worth $745,067,636.
- Accession
- 0001534261-19-000011
- Filer
- CIK 1534261
- Filed
- 2019-11-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2019
A holdings report, 26 entries on the cover page, a total value of $745,067,636 stated on the cover page (in dollars after the unit check, H1), rows summing to $745,067,632 with VALUE read as dollars, detected, 13F file number 028-17113. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPARK THERAPEUTICS INC | 84652J103 | COM | 863,300 | $83,722,834 | dollars, detected | |
| INVITAE CORP | 46185L103 | COM | 1,038,388 | $83,623,366 | dollars, detected | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 940,000 | $69,061,800 | dollars, detected | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 880,000 | $66,281,600 | dollars, detected | |
| MYOKARDIA INC | 62857M105 | COM | 1,115,000 | $58,147,250 | dollars, detected | |
| BLUEBIRD BIO INC | 09609G100 | COM | 612,500 | $56,239,750 | dollars, detected | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 400,000 | $56,116,000 | dollars, detected | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 600,000 | $48,252,000 | dollars, detected | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 935,000 | $30,294,000 | dollars, detected | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 860,000 | $24,157,400 | dollars, detected | |
| CAREDX INC | 14167L103 | COM | 1,000,000 | $22,610,000 | dollars, detected | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 1,128,075 | $19,414,170 | dollars, detected | |
| ILLUMINA INC | 452327109 | COM | 60,000 | $18,253,200 | dollars, detected | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 820,000 | $14,842,000 | dollars, detected | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 300,000 | $14,556,000 | dollars, detected | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 463,125 | $13,439,761 | dollars, detected | |
| ALECTOR INC | 014442107 | COMMON STOCK | 811,039 | $11,695,182 | dollars, detected | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 650,000 | $9,958,000 | dollars, detected | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 1,523,960 | $9,844,781 | dollars, detected | |
| EDITAS MEDICINE INC | 28106W103 | COM | 415,000 | $9,437,100 | dollars, detected | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 300,000 | $7,164,000 | dollars, detected | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 844,285 | $5,266,938 | dollars, detected | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 310,000 | $3,682,800 | dollars, detected | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 100,000 | $3,394,000 | dollars, detected | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 75,000 | $2,820,000 | dollars, detected | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 130,000 | $2,793,700 | dollars, detected |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001534261-19-000011 | this filing | 2019-11-12 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001534261-19-000012 | superseded | 2019-11-12 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001534261-20-000001 | base | 2020-01-03 | acceptance time not in the bulk data set |